![Interoperability and Price Transparency in the 21st Century Cures Act: A Payer’s Perspective [Sponsored]](https://www.mediformatica.com/wp-content/uploads/2023/03/interoperability-and-price-transparency-in-the-21st-century-cures-act-a-payers-perspective-sponsored.jpg)
Although it was signed into law in 2016, portions of the 21st Century Cures Act, the provisions designed to support interoperability continue created the need for new rules by the Centers for Medicare and…
Continue Reading
The Federal Trade Commission has started cracking down on digital health companies for allegedly sharing consumers’ health data for advertising purposes. Last month, the agency said GoodRx had shared personal health information with third parties…
Continue Reading
GoodRx reported falling revenue for the fourth quarter, but its stock rallied early Wednesday after beating earnings expectations. The company, best known for its drug cost transparency tools, reported $184.1 million in revenue for Q4…
Continue Reading
Shared decision-making tools that also integrate information about healthcare costs both help support patient empowerment and help patients manage their medical expenses, according to a new FAIR Health report. The report, which looked at…
Continue Reading
Stuart Hanson, CEO of Avaneer HealthInteroperability in the U.S. healthcare system has been an ongoing challenge. While there are several industry initiatives that are going to advance the industry and make incremental progress toward…
Continue Reading
What You Should Know:– In the IT advisory space, many firms perform well, but the breadth of their expertise varies—some firms offer many services, while others focus on a specific area. KLAS’s latest report…
Continue Reading
Heather Bassett, M.D., Chief Medical Officer, XSOLISToday’s relationship between payers and providers is more fraught than ever. With a history of transactional, often adversarial, fee-for-service contract negotiations, it’s no wonder that the healthcare industry…
Continue Reading
